Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis

Schizophrenia Bulletin

Volumn 39, Issue 6, 2013, Pages 1328-1336

  Roiser, Jonathan P ^a   Howes, Oliver D ^b,c   Chaddock, Christopher A ^b   Joyce, Eileen M ^d   McGuire, Philip ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aberrant salience; Dopamine; Functional magnetic resonance imaging; Positron emission tomography; Psychosis; Salience attribution test

Indexed keywords

6 FLUORODOPAMINE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DELUSION; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MALE; MENTAL HEALTH; NERVE POTENTIAL; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; REWARD; WORKING MEMORY;

ABERRANT SALIENCE; DOPAMINE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PSYCHOSIS; SALIENCE ATTRIBUTION TEST;

ADULT; BASAL GANGLIA; CEREBRUM; DELUSIONS; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84886060735     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs147     Document Type: Article

References (41)

1. Shaner A. Delusions, superstitious conditioning and chaotic dopamine neurodynamics. Med Hypotheses. 1999;52:119-123. (Pubitemid 29178631)
2. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13-23. (Pubitemid 36042420)
3. Miller R. Striatal dopamine in reward and attention: a system for understanding the symptomatology of acute schizophrenia and mania. Int Rev Neurobiol. 1993;35:161-278.
4. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28:309-369. (Pubitemid 29012677)
5. Corlett PR, Frith CD, Fletcher PC. From drugs to deprivation: a Bayesian framework for understanding models of psychosis. Psychopharmacology (Berl). 2009;206:515-530.
6. Lodge DJ, Grace AA. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci. 2007;27:11424-11430. (Pubitemid 47621327)
7. Lodge DJ, Grace AA. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia. Int J Neuropsychopharmacol 2011;18:1-8.
8. Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des. 2009;15:2550-2559.
9. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13-20.
10. Howes OD, Bose SK, Turkheimer F, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168:1311-1317.
11. Howes O, Bose S, Turkheimer F, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011;16:885-886.
12. Schott BH, Minuzzi L, Krebs RM, et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci. 2008;28:14311-14319.
13. Roiser JP, Stephan KE, den Ouden HE, Barnes TR, Friston KJ, Joyce EM. Do patients with schizophrenia exhibit aberrant salience? Psychol Med. 2009;39:199-209.
14. Murray GK, Clark L, Corlett PR, et al. Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry. 2008;8:34.
15. Murray GK, Corlett PR, Clark L, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008;13:239, 267-276.
16. Corlett PR, Murray GK, Honey GD, et al. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain. 2007;130:2387-2400. (Pubitemid 47327635)
17. Jensen J, Willeit M, Zipursky RB, et al. The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology. 2008;33:473-479.
18. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 2006;29:409-416. (Pubitemid 43063297)
19. Romaniuk L, Honey GD, King JR, et al. Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. Arch Gen Psychiatry. 2010;67:1246-1254.
20. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin rewardseeking behaviour in humans. Nature. 2006;442:1042-1045. (Pubitemid 44330261)
21. Schlagenhauf F, Sterzer P, Schmack K, et al. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry. 2009;65:1032-1039.
22. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl). 2006;187:222-228. (Pubitemid 44015616)
23. Waltz JA, Schweitzer JB, Gold JM, et al. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology. 2009;34:1567-1577.
24. Roiser JP, Stephan KE, den Ouden HE, Friston KJ, Joyce EM. Adaptive and aberrant reward prediction signals in the human brain. Neuroimage. 2010;50:657-664.
25. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39:964-971. (Pubitemid 43904432)
26. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33;quiz 34-57. (Pubitemid 29001829)
27. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276. (Pubitemid 18039085)
28. Nelson HE. National Adult Reading Test (NART): Test Manual. Windsor, United Kingdom: NFER-Nelson; 1982.
29. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation; 1999.
30. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233-1239. (Pubitemid 36918259)
31. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46. (Pubitemid 20255621)
32. Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224-247. (Pubitemid 36959351)
33. Thompson JL, Urban N, Slifstein M, et al. Striatal dopamine release in schizophrenia comorbid with substance dependence [published online ahead of print August 7, 2012]. Mol Psychiatry. doi:10.1038/mp.2012.109
34. Wittmann BC, Bunzeck N, Dolan RJ, Düzel E. Anticipation of novelty recruits reward system and hippocampus while promoting recollection. Neuroimage. 2007;38:194-202. (Pubitemid 47429984)
35. Floresco SB, Todd CL, Grace AA. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci. 2001;21:4915-4922. (Pubitemid 32565650)
36. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a crosssectional and longitudinal MRI comparison. Lancet. 2003;361:281-288. (Pubitemid 36126187)
37. Valli I, Stone J, Mechelli A, et al. Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis. Biol Psychiatry. 2011;69:97-99.
38. Lodge DJ, Grace AA. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology. 2006;31: 1356-1361.
39. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci. 2003;6:968-973. (Pubitemid 37064759)
40. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 2001;11:543-550. (Pubitemid 33100375)
41. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology. 2009;34:2675-2690.